Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families

Improving Communication With and Building a Stronger Medical Home Among Spanish-speaking Families in the Center for Cancer and Blood Disorders

This study will seek to improve communication with Spanish speaking families and patients with Cancer and Blood Disorders.

Study Overview

• Status: Recruiting
• Conditions: Leukemia; Non Hodgkin Lymphoma
• Intervention / Treatment: Other: Interview

Detailed Description

The Principal Investigator seeks to improve communication with Spanish speaking families with the following goals: 1) to increase patient and family sense of inclusion in the medical community, 2) to increase patient and family medical knowledge and understanding, 3) to improve patient adherence with critical medical regimens, and ultimately, 4) to increase equality of comprehensive medical care delivery across the continuum of care including physical and psychosocial domains.

• Study Type: Observational
• Enrollment (Estimated): 20

Contacts and Locations

• Study Contact: Name: Wendy Moore; Phone Number: 1-720-777-6353; Email: wendy.moore@childrenscolorado.org

Study Locations

• United States
  • Colorado
    • Aurora, Colorado, United States, 80045
      • Recruiting
      • Children's Hospital Colorado
      • Contact: Wendy Moore; Phone Number: 720-777-6353; Email: wendy.moore@childrenscolorado.org
      • Principal Investigator: Ashley Rogers

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: No older than 22 years (Child, Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

Patients eligible for enrollment are identified from EPIC electronic medical record with notification for newly diagnosed families of Spanish language preference.

Description

Inclusion Criteria:

• 0 to 22 years of age
• Diagnosis of leukemia or non-Hodgkin lymphoma
• Spanish as preferred language for patient, parent or guardian
• Received or receiving care at the Center for Cancer and Blood Disorders (CCBD)

Exclusion Criteria:

• Patients without oncologic diagnosis
• Patients with parents whose language preference is English
• Patients who received care solely outside of the CCBD

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Patients treated in CCBD; Patients who are currently receiving therapy at the Center for Cancer and Blood Disorders

Other: Interview; Patient/parent dyads expressing interest will be interviewed by a bilingual Spanish certified provider via televideo with as needed interpreter support. Interviews will be audio recorded for review and translation purposes and then will be destroyed. Interview format will be supportive and information seeking only with reassurance that purpose is for care improvement and that all answers will be evaluated without association to patient name. Interviews will then be translated and reviewed by the PI for themes regarding perceived clinic successes and perceived clinic barriers in communication or care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Determine a baseline level of Spanish speaking patient satisfaction of care	Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers.	12 months
Determine a baseline level of Spanish Speaking family satisfaction of care	Understand the patient experience using qualitative interview of Spanish speaking patients and families Determine satisfaction based on open-ended question with unsatisfied to satisfied as markers.	12 months
Determine effects of language barrier on Spanish speaking patient needs	Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine a list or pattern of common patient needs.	12 months
Determine the effect of language barrier on barriers to patient care	Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine a list or pattern of common barriers to patient care.	12 months
Effect of language barrier on efficiency of access to care	Understand the patient experience using qualitative interview of Spanish speaking patients and families. Determine satisfaction based on open-ended question to determine how quickly patient was able to receive care.	12 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Determine patient interest in home telemedicine support program	Open-ended questions will be used to determine level of interest in a telemedicine support program.	12 months
Determine patient interest in home telemedicine support program after discharge	Open-ended questions will be used to determine level of interest in a telemedicine support program to be used after discharge from hospital.	12 months
Determine Spanish speaking patient interest in telemedical check-ins during intensive phases of therapy	Open-ended questions will be used to determine level of interest in a telemedical support during treatment.	12 months
Determine Spanish speaking patient interest in medication assistance during intensive phases of therapy	Open-ended questions will be used to determine level of interest in a telemedical medication support during therapy.	12 months
Determine Spanish speaking patient interest in medical check-ins during maintenance	Open-ended questions will be used to determine level of interest in a telemedical check-ins during maintenance.	12 months
Determine Spanish speaking patient interest in medication assistance during maintenance	Open-ended questions will be used to determine level of interest in a telemedical medication assistance during maintenance.	12 months

Collaborators and Investigators

• Sponsor: University of Colorado, Denver
• Collaborators: Children's Hospital Colorado
• Investigators: Principal Investigator: Ashley Rogers, Children's Hospital Colorado

Study record dates

Study Major Dates

• Study Start (Actual): March 17, 2022
• Primary Completion (Estimated): November 4, 2024
• Study Completion (Estimated): November 4, 2025

Study Registration Dates

• First Submitted: June 15, 2022
• First Submitted That Met QC Criteria: June 15, 2022
• First Posted (Actual): June 21, 2022

Study Record Updates

• Last Update Posted (Estimated): December 11, 2023
• Last Update Submitted That Met QC Criteria: December 8, 2023
• Last Verified: December 1, 2023

More Information

Terms related to this study

• Keywords: Spanish-speaking
• Additional Relevant MeSH Terms: Immune System Diseases; Neoplasms by Histologic Type; Neoplasms; Lymphoproliferative Disorders; Lymphatic Diseases; Immunoproliferative Disorders; Lymphoma; Lymphoma, Non-Hodgkin
• Other Study ID Numbers: 21-4238.cc; NCI-2022-04061 (Other Identifier: CTRP)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No